Track MiniMed Group, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

MiniMed Group, Inc. MMED · Stock Open MiniMed Group, Inc. in new tab

17.99 USD
EPS
-1.53
P/B
1.40
ROE
-8.66
Target Price
25.33 USD
Loading chart...
Key Metrics
Earnings dateDec. 30, 2026
EPS-1.53
Book Value12.87
Price to Book1.40
Debt/Equity1.63
% Insiders0.596%
Growth
Revenue Growth0.17%
Estimates
Forward P/E25.52
Forward EPS0.71
Target Mean Price25.33

DCF valuation

Model fair value for MiniMed Group, Inc. (MMED)
Result
Sign in to run the valuation for MMED.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
15 analysts · consensus Buy · mean target 25.33 USD (low 15.00, high 30.00) · as of 15 Nov 2026
Low 15.00
Mean 25.33
High 30.00
Price 17.99
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

MiniMed Group, Inc. Logo MiniMed Group, Inc. Analysis (MMED)

US Healthcare Official Website Stock

Is MiniMed Group, Inc. a good investment? MiniMed Group, Inc. (MMED) is currently trading at 17.99 USD. Market analysts have a consensus price target of 25.33 USD. This suggests a potential upside from current levels.

Earnings Schedule: MiniMed Group, Inc. is expected to release its next earnings report on Dec. 30, 2026. The market consensus estimate for Forward EPS is 0.71.

Investor FAQ

Does MiniMed Group, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is MiniMed Group, Inc.?

MiniMed Group, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Dec. 30, 2026. The company currently has a trailing EPS of -1.53.

Company Profile

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.

Exchange Ticker
NASDAQ MMED
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion